4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021846
CEO bought 48,076 shares at $0.52 ($25,000)
From the SEC's structured data for this filing
Trades in this filing
Woods Lori A · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 1 in the form | +48,076 | $0.52 | $25,000 | 48,076 | D |
| Open-market purchases · 48,076 sh · avg $0.52 · $25,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 2 in the form Warrant (right to buy) | +24,038 | 611,538 | D |
Loading xslF345X03/rdgdoc.xml…